Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2269511-95-5
2. Anrikefon [inn]
3. 22scy98bxv
4. Unii-22scy98bxv
5. (r)-n-[(r)-1-(2-acetyl-2,7-diazaspiro[3.5]nonan-7-yl)-6-amino-1-oxo-2-hexyl]-2-[(r)-2-[(r)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-methylpentanamide
6. 1-(7-(d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl)-2,7-diazaspiro(3.5)non-2-yl)ethanone
7. 1-(7-(d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl)- 2,7-diazaspiro(3.5)nonan-2-yl)ethan-1-one
8. Ethanone, 1-(7-(d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl)-2,7-diazaspiro(3.5)non-2-yl)-
9. 1-[7-(d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl)- 2,7-diazaspiro[3.5]nonan-2-yl]ethan-1-one
10. 1-[7-(d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl)-2,7-diazaspiro[3.5]non-2-yl]ethanone
11. Ethanone, 1-[7-(d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl)-2,7-diazaspiro[3.5]non-2-yl]-
12. Anrikefon [who-dd]
13. Orb1744249
14. Chembl5095089
15. Schembl20669227
16. Glxc-27229
17. Hsk21542
18. Hy-p3445
19. Da-70882
20. Sy412371
21. Cs-0541917
22. H36714
23. (2r)-n-[(2r)-1-(2-acetyl-2,7-diazaspiro[3.5]nonan-7-yl)-6-amino-1-oxohexan-2-yl]-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanamide
| Molecular Weight | 703.9 g/mol |
|---|---|
| Molecular Formula | C39H57N7O5 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 17 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 180 |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Complexity | 1150 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
14
PharmaCompass offers a list of Anrikefon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Anrikefon manufacturer or Anrikefon supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Anrikefon manufacturer or Anrikefon supplier.
A Anrikefon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anrikefon, including repackagers and relabelers. The FDA regulates Anrikefon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anrikefon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Anrikefon supplier is an individual or a company that provides Anrikefon active pharmaceutical ingredient (API) or Anrikefon finished formulations upon request. The Anrikefon suppliers may include Anrikefon API manufacturers, exporters, distributors and traders.
Anrikefon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anrikefon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Anrikefon GMP manufacturer or Anrikefon GMP API supplier for your needs.
A Anrikefon CoA (Certificate of Analysis) is a formal document that attests to Anrikefon's compliance with Anrikefon specifications and serves as a tool for batch-level quality control.
Anrikefon CoA mostly includes findings from lab analyses of a specific batch. For each Anrikefon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anrikefon may be tested according to a variety of international standards, such as European Pharmacopoeia (Anrikefon EP), Anrikefon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anrikefon USP).
